4//SEC Filing
Bruno Julianne 4
Accession 0000950170-25-023387
CIK 0001674416other
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 5:35 PM ET
Size
9.5 KB
Accession
0000950170-25-023387
Insider Transaction Report
Form 4
Bruno Julianne
Chief Operating Officer
Transactions
- Exercise/Conversion
Common Shares
2025-02-18+650→ 7,395 total - Sale
Common Shares
2025-02-19$52.80/sh−333$17,582→ 7,062 total - Exercise/Conversion
Restricted Stock Units
2025-02-18−650→ 650 total→ Common Shares (650 underlying)
Holdings
- 7,088(indirect: The Julianne Bruno 2022 GRAT)
Common Shares
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.
- [F2]Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person.
- [F3]This restricted stock unit award was granted on February 18, 2022 with respect to 2,600 Common Shares, with (i) one quarter of the shares vesting on February 18, 2023, (ii) one quarter of the shares vesting on February 18, 2024, (iii) one quarter of the shares vesting on February 18, 2025, and (iv) one quarter of the shares vesting on February 18, 2026.
Documents
Issuer
CRISPR Therapeutics AG
CIK 0001674416
Entity typeother
Related Parties
1- filerCIK 0002019645
Filing Metadata
- Form type
- 4
- Filed
- Feb 18, 7:00 PM ET
- Accepted
- Feb 19, 5:35 PM ET
- Size
- 9.5 KB